| number |
Reagent products |
Project development and listing progress |
| Project Development |
Product registration inspection |
Clinical trial implementation |
Product Registration Review |
Market production |
| 1 |
Hepatitis B two-and-a-half diagnostic kit (dry fluorescence luminescence method) |
|
| 2 |
Hepatitis B virus surface antigen, hepatitis C virus antibody, syphilis antibody, human immunodeficiency virus antibody combined detection kit (dry fluorescence luminescence method) |
|
| 3 |
Hepatitis B virus surface antigen detection kit (dry fluorescence luminescence method) |
|
| 4 |
Syphilis antibody detection kit (dry fluorescence luminescence method) |
|
| 5 |
Human Immunodeficiency Virus Antibody Detection Kit (Dry Fluorescence Luminescence Method) |
|
| 6 |
Hepatitis C virus antibody detection kit (dry fluorescence luminescence method) |
|
| 7 |
Anti-cyclic citrullinated peptide antibody (anti-CCP) detection kit (dry fluorescence luminescence method) |
|
| 8 |
Rheumatoid disease five detection kit (dry fluorescence luminescence method) |
|
| 9 |
Respiratory five-item detection kit A (dry fluorescence luminescence method) |
|
| 10 |
Respiratory five-item detection kit B (dry fluorescence luminescence method) |
|
| 11 |
Rabies virus IgG antibody detection kit (dry fluorescence luminescence method) |
|
| 12 |
Tetanus antibody detection kit (dry fluorescence luminescence method) |
|
| 13 |
Human Immunodeficiency Virus Antibody Detection Kit (Colloidal Gold Method) |
|